LAVA Therapeutics, N.V. (@lavatx) 's Twitter Profile
LAVA Therapeutics, N.V.

@lavatx

Immuno-oncology company focused on developing its proprietary Gammabody™ platform of bispecific gamma delta T cell engagers to treat cancer.

ID: 1318269638468378625

linkhttp://www.lavatherapeutics.com calendar_today19-10-2020 19:15:58

223 Tweet

265 Takipçi

375 Takip Edilen

LAVA Therapeutics, N.V. (@lavatx) 's Twitter Profile Photo
LAVA Therapeutics, N.V.
@lavatx

3 years ago

We’re gearing up for #SITC2022, where we’re presenting data demonstrating on-mechanism pharmacodynamics for LAVA-051, our CD1d-targeting #gammadelta T cell engager, in patients with #CLL and #multiplemyeloma. Learn more: bit.ly/3fJBfsl #immunooncology

We’re gearing up for #SITC2022, where we’re presenting data demonstrating on-mechanism pharmacodynamics for LAVA-051, our CD1d-targeting #gammadelta T cell engager, in patients with #CLL and #multiplemyeloma. Learn more: bit.ly/3fJBfsl #immunooncology